PRFX
PRF Technologies·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 2
Bearish signal 2
EPS Beats Expectation
Price Hits New Low
Price Hits 52-week Low
RSI Oversold
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PRFX
Prf Technologies Ltd.
A clinical stage specialty pharmaceutical company focused on providing an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates
65 Yigal Alon St., Tel Aviv 6744316, Israel
--
PRF Technologies Ltd., incorporated and commenced business in November 2007. PRF Technologies Ltd., a diversified and innovative company, is committed to advancing specialty drug therapies and artificial intelligence-driven energy analysis. Its drug programs focus on drug formulation improvement and sustained-release drug delivery technology, aiming to improve patient efficacy while reducing dependence on opioids and complex dosing regimens. Through its DeepSolar platform, the company develops advanced artificial intelligence solutions designed to help solar asset owners and operators monitor, predict and optimize energy performance throughout the asset lifecycle.
Company Financials
EPS
PRFX has released its 2023 Q3 earnings. EPS was reported at 0.48, versus the expected 0, beating expectations. The chart below visualizes how PRFX has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
